308 related articles for article (PubMed ID: 8909667)
1. Inhaled aerosolized prostacyclin and nitric oxide as selective pulmonary vasodilators in ARDS--a pilot study.
Van Heerden PV; Blythe D; Webb SA
Anaesth Intensive Care; 1996 Oct; 24(5):564-8. PubMed ID: 8909667
[TBL] [Abstract][Full Text] [Related]
2. Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure.
Meyer J; Theilmeier G; Van Aken H; Bone HG; Busse H; Waurick R; Hinder F; Booke M
Anesth Analg; 1998 Apr; 86(4):753-8. PubMed ID: 9539597
[TBL] [Abstract][Full Text] [Related]
3. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome.
Walmrath D; Schneider T; Schermuly R; Olschewski H; Grimminger F; Seeger W
Am J Respir Crit Care Med; 1996 Mar; 153(3):991-6. PubMed ID: 8630585
[TBL] [Abstract][Full Text] [Related]
4. Effects of inhaled prostacyclin as compared with inhaled nitric oxide in a canine model of pulmonary microembolism and oleic acid edema.
Zwissler B; Welte M; Habler O; Kleen M; Messmer K
J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):634-40. PubMed ID: 8664452
[TBL] [Abstract][Full Text] [Related]
5. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
[TBL] [Abstract][Full Text] [Related]
6. Inhaled nitric oxide for the adult respiratory distress syndrome.
Rossaint R; Falke KJ; López F; Slama K; Pison U; Zapol WM
N Engl J Med; 1993 Feb; 328(6):399-405. PubMed ID: 8357359
[TBL] [Abstract][Full Text] [Related]
7. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
Kieler-Jensen N; Ricksten SE; Stenqvist O; Bergh CH; Lindelöv B; Wennmalm A; Waagstein F; Lundin S
J Heart Lung Transplant; 1994; 13(3):366-75. PubMed ID: 8061011
[TBL] [Abstract][Full Text] [Related]
8. Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension.
Max M; Kuhlen R; Dembinski R; Rossaint R
Intensive Care Med; 1999 Oct; 25(10):1147-54. PubMed ID: 10551974
[TBL] [Abstract][Full Text] [Related]
9. Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury.
Jacobs BR; Brilli RJ; Ballard ET; Passerini DJ; Smith DJ
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1536-42. PubMed ID: 9817705
[TBL] [Abstract][Full Text] [Related]
10. Inhaled aerosolized prostacyclin as a selective pulmonary vasodilator for the treatment of severe hypoxaemia.
Van Heerden PV; Webb SA; Hee G; Corkeron M; Thompson WR
Anaesth Intensive Care; 1996 Feb; 24(1):87-90. PubMed ID: 8669661
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of inhaled nitric oxide and positive end-expiratory pressure during mechanical ventilation in acute respiratory distress syndrome.
Okamoto K; Kukita I; Hamaguchi M; Motoyama T; Muranaka H; Harada T
Artif Organs; 2000 May; 24(5):390-5. PubMed ID: 10848682
[TBL] [Abstract][Full Text] [Related]
12. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
13. Inhaled nitric oxide and inhaled prostacyclin in acute respiratory distress syndrome: what is the evidence?
Puri N; Dellinger RP
Crit Care Clin; 2011 Jul; 27(3):561-87. PubMed ID: 21742217
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled aerosolized prostacyclin.
Rocca GD; Coccia C; Pompei L; Ruberto F; Venuta F; De Giacomo T; Pietropaoli P
J Cardiothorac Vasc Anesth; 2001 Apr; 15(2):224-7. PubMed ID: 11312484
[TBL] [Abstract][Full Text] [Related]
15. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
Haraldsson A; Kieler-Jensen N; Nathorst-Westfelt U; Bergh CH; Ricksten SE
Chest; 1998 Sep; 114(3):780-6. PubMed ID: 9743166
[TBL] [Abstract][Full Text] [Related]
16. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome.
Zwissler B; Kemming G; Habler O; Kleen M; Merkel M; Haller M; Briegel J; Welte M; Peter K
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1671-7. PubMed ID: 8970353
[TBL] [Abstract][Full Text] [Related]
17. Indications, modifications and technique of ECMO with or without NO-therapy.
Pappert D; Falke KJ
Acta Anaesthesiol Scand Suppl; 1996; 109():117-20. PubMed ID: 8901974
[No Abstract] [Full Text] [Related]
18. Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS.
van Heerden PV; Barden A; Michalopoulos N; Bulsara MK; Roberts BL
Chest; 2000 Mar; 117(3):819-27. PubMed ID: 10713012
[TBL] [Abstract][Full Text] [Related]
19. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
20. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension.
Walmrath D; Schermuly R; Pilch J; Grimminger F; Seeger W
Eur Respir J; 1997 May; 10(5):1084-92. PubMed ID: 9163651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
